Cancer trials: Search results
Results: 152 items found. Showing page 6 of 6.
Refine results
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
Trial short name: RELATIVITY-127
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 3
Randomized trial of hypofractionated locoregional radiotherapy in breast cancer and lymphedema
Trial short name: RHEAL
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
Radiation OmisSion in PAtients with CLinically Node Negative Breast Cancer undergoing Lumpectomy and with a PathologIc Complete REsponse after Neoadjuvant Chemotherapy
Trial short name: ROSALIE
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Other
A Phase I-II Study of Stereotactic Body Radiation Therapy for Breast Cancer
Trial short name: SBRT BREAST
Cancer type: Breast
Cancer location: Breast
Disease stage: Advanced Cancer
Trial phase: Phase 1
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
Trial short name: SEAMARK
Cancer type: Gastrointestinal
Cancer location: Colorectal
Disease stage: Early Cancer
Trial phase: Phase 2
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator’s Choice Chemotherapy in Secondor Third-Line Recurrent or Metastatic Cervical Cancer
Trial short name: SGNTV-003
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
A Single-Arm, Open-Label, Phase 1b/2 Study of SLC-391, an AXL Inhibitor, in Combination with Pembrolizumab in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Trial short name: SKYLITE
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
A Phase II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of AZD0171 in Combination with Durvalumab and Chemotherapy in Participants with Locally Advanced or Metastatic Solid Tumours
Trial short name: SOLIS
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 2
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II: A Phase II Randomized Controlled Trial
Trial short name: SPARTACUS II
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 2
A Feasibility Trial of Lymphatic Mapping with SPECT-CT for Evaluating Contralateral Disease in Lateralized Oropharynx Cancer using 99m-Technetium Sulfur Colloid
Trial short name: SPECT-CT
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumor Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumors
Trial short name: SPINET
Cancer type: Neuroendocrine
Cancer location: Neuroendocrine
Disease stage: Advanced Cancer
Trial phase: Phase 3
A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer
Trial short name: Stablemates
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 3
Stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic breast cancer: A phase I feasibility trial
Trial short name: STOMP
Cancer type: Breast
Cancer location: Breast
Disease stage: Advanced Cancer
Trial phase: Phase 1
A Randomized Phase III Trial of the Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Trial short name: STOP GAP
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early and Advanced Cancer
Trial phase: Phase 3
TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
Trial short name: TACTIVE ABEMA
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
TACTIVE-U: An Interventional Safety and Efficacy Phase 1b/2, Open-label Umbrella Study to Investigate Tolerability, PK, and Antitumor Activity of ARV-471 (PF-07850327), an Oral Proteolysis Targeting Chimera, in Combination With Other Anticancer Treatments in Participants Aged 18 Years and Over with ER+ Advanced or Metastatic Breast Cancer, Sub-study B (ARV-471 in combination with Ribociclib)
Trial short name: TACTIVE RIBO
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
A randomized Trial of Regional Radiotherapy in biomarker low risk node positive and T3N0 Breast cancer
Trial short name: Tailor RT (MA39)
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
Tumor Immunotherapy and MicrobiomE Analysis
Trial short name: TIME
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Advanced Cancer
Trial phase: Other
TiNivo-2: A Phase 3, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma Who Have Progressed Following One or Two Lines of Therapy Where One Line Has an Immune Checkpoint Inhibitor
Trial short name: TiNivo-2
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Early Cancer
Trial phase: Phase 3
TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer
Trial short name: TOPCOP3
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase: Other
Triple negative breast Cancer markers in liquid biopsies using artificial intelligence
Trial short name: TRICIA study
Cancer type:
Cancer location:
Disease stage: Early Cancer
Trial phase: Other
EF-32 (TRIDENT): A PIVOTAL RANDOMIZED, OPEN-LABEL STUDY OF OPTUNE® (TTFIELDS, 200KHZ) CONCOMITANT WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA
Trial short name: Trident EF-32
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase:
UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: A Phase 2 Trial (UNITED trial)
Trial short name: UNITED
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionationed Boost Trial for High Grade Glioma in the Elderly
Trial short name: UNITED2
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
A Phase 3, Randomized, Open-Label, Multicenter Trial of ARV-471 (PF-07850327) vs Fulvestrant in Participants with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Whose Disease Progressed After Prior Endocrine Based Treatment for Advanced Disease
Trial short name: VERITAC-2
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
